Iron infusion for anemia in peritoneal dialysis patients
Treatments studied
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This study tests an intravenous (IV) iron treatment called iron isomaltoside for people on peritoneal dialysis who have anemia (low red blood cells). It aims to improve your hemoglobin and iron levels, which may help you feel more energetic and reduce fatigue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older, have been on peritoneal dialysis for at least 3 months, and weigh at least 110 pounds.
- Your hemoglobin (the part of blood that carries oxygen) is 110 or lower, and your iron levels are low.
- You have not taken iron supplements (by mouth or IV) in the last 4 weeks, and you have not used certain other anemia medications except for EPO in that time.
- Your anemia is not caused by other conditions like bleeding, blood disorders, or autoimmune diseases.
- You do not have severe liver problems, active infections, serious allergies to iron, or a history of cancer in the last 5 years.
- You have not had a recent heart attack, stroke, or blood clot in the last 6 months, and you do not have severe heart failure or unsafe heart rhythms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a higher or lower dose of iron works better for people on peritoneal dialysis who have low iron levels. It aims to find the best way to treat iron deficiency in this group.
This study compares two intravenous iron treatments to see if one works as well as the other in people with iron deficiency anemia. It may help improve your iron levels and reduce anemia symptoms.
This trial tests whether giving an intravenous iron supplement (ferric derisomaltose) can help prevent anemia and improve quality of life in obese patients who have low iron stores. It aims to see if this treatment can boost energy and reduce fatigue.
This trial tests an iron infusion called ferric carboxymaltose to treat iron deficiency anemia in children and teens seen in the emergency department. It aims to improve their hemoglobin levels and overall health.
This study tests whether intravenous iron can improve outcomes for people with non-ischemic heart failure and low ejection fraction who are also iron deficient. If you fit the criteria, you may receive iron infusions to see if it helps your heart function and symptoms.
This trial tests whether giving intravenous iron to adults hospitalized with heart failure and low iron levels helps improve their health. You may be eligible if you have heart failure with reduced pumping function and low iron stores.
Hear when a new Renal Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.